South Korea: The de-escalation strategy is a reasonable and safe strategy option following myocardial infarction (MI) in patients with high ischemic risk, a recent study published in JAMA Cardiology.
South Korea: The medical therapy with beta-blockers or RAS inhibitors at discharge is tied to better 2-year clinical outcomes in patients with mildly reduced left ventricular ejection fraction (EF).